Insiders who reported open-market trades in the last 12 months at the companies Harry Skip Kiil files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
Geoffrey Martha - $4.75M in MDT purchases and sales in the last 12 months
Gregory L. Smith - $3.06M in MDT purchases and sales in the last 12 months
Michael Marinaro - $1.00M in MDT purchases and sales in the last 12 months
Matthew R. Walter - $258K in MDT purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Harry Skip Kiil is a corporate insider, tracked as EVP & President Cardiovascular of Medtronic plc (MDT). InsiderAlpha holds 9 primary Form 4 filings for them, the earliest from 2025, updated as new SEC EDGAR filings are processed.
How many SEC Form 4 filings has Harry Skip Kiil submitted recently?
2 primary Form 4 filings in the last 90 days, covering 1 company.
Has Harry Skip Kiil been buying or selling stock?
Recorded transactions: 0 open-market purchases and 10 open-market sales ($6.40M) across all tracked filings.
Harry Skip Kiil is EVP & President Cardiovascular of Medtronic plc (MDT). 9 SEC Form 4 filings on record going back to 2025, most recently on 17 September 2026. Most recent open-market trade: sold $139K of MDT on 17 September 2026. Lifetime open-market sales: $6.40M.
Recent transactions
20
The latest 20 SEC Form 4 transactions reported by Harry Skip Kiil.
InsiderAlpha's records for Harry Skip Kiil go back to 2025: 9 primary Form 4 filings, an average of 4.5 per year. No recorded transaction carries a Rule 10b5-1 plan flag. An absent flag does not establish whether a transaction was pre-arranged or discretionary.
